Pluristem Therapeutics Soars 15% (PSTI, BBY, KCG, EXEL, IPG)
Pluristem Therapeutics Inc (NASDAQ:PSTI) surged up 14.50% to $3.79 on a traded volume of 1.72 million shares. The Company said that it has saved the life of a second patient with aplastic bone marrow. There was a condition in which the patient’s bone marrow doesn’t produce new blood cells. Pluristem has applied for orphan drug status from the U.S. Food and Drug Administration for its treatment, based on stem cells derived from placenta. The Company is working to use placenta-derived stem cells to treat a variety of other conditions,
Best Buy Co Inc (NYSE:BBY) soared 18.88% to $20.97 on a traded volume of 11.58 million shares. The Company’s founder and former chairman Richard Schulze offered to buy the remaining shares of the Company that he doesn’t already own in a deal that values the retailer at up to $8.84 billion or $24 to$26 per share.
Knight Capital Group Inc (NYSE:KCG) declined 25.43% to $3.02. Knight Capital Group Inc announced $400 million in equity financing with Wall Street firms including Jefferies Group Inc, Blackstone, GETCO LLC, Stephens and Stifel Financial Corp. Under the terms of the transaction, Knight issued 2% preferred shares that may be converted into common stock at $1.50 per share.
Exelixis Inc (NASDAQ:EXEL) plunged 8.25% to $5.12. The Company intends to offer 20 million shares and $225 million in debt to raise funds for clinical trials and other general corporate purpose. The biotechnology company expects to raise about $105.6 million in net proceeds from the common stock offering. Interest on the notes will be payable semiannually in arrears on February 15 and August 15 of each year.
Interpublic Group of Companies Inc (NYSE:IPG) slipped 8.84% to $10.0. There was rumor that France’s Publicis Group SA is considering to buy the Company for $15 per share or $6 billion.